Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

GSK

Gsk (GSK)

Gsk Plc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:LSE:GSK
日付受信時刻ニュースソース見出しコード企業名
2024/07/2320 : 07Alliance NewsAlliance NewsGSK announces promising trial data for ViiV Healthcare HIV drugsLSE:GSKGsk Plc
2024/07/2320 : 07Alliance NewsAlliance NewsGSK announces promising trial data for ViiV Healthcare HIV drugsLSE:GSKGsk Plc
2024/07/1918 : 36RNS Regulatory NewsGSK PLC Blenrep EMA Filing AcceptanceLSE:GSKGsk Plc
2024/07/1916 : 12Alliance NewsAlliance NewsGSK drug for multiple myeloma accepted for European regulatory reviewLSE:GSKGsk Plc
2024/07/1916 : 12Alliance NewsAlliance NewsGSK drug for multiple myeloma accepted for European regulatory reviewLSE:GSKGsk Plc
2024/07/1823 : 30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
2024/07/1623 : 30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
2024/07/1523 : 30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
2024/07/1419 : 18Alliance NewsAlliance NewsGSK moves to new global headquarters in return to central LondonLSE:GSKGsk Plc
2024/07/1419 : 18Alliance NewsAlliance NewsGSK moves to new global headquarters in return to central LondonLSE:GSKGsk Plc
2024/07/1223 : 30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
2024/07/0821 : 32Alliance NewsAlliance NewsIN THE KNOW: UBS downgrades GSK and hacks share price targetLSE:GSKGsk Plc
2024/07/0821 : 32Alliance NewsAlliance NewsIN THE KNOW: UBS downgrades GSK and hacks share price targetLSE:GSKGsk Plc
2024/07/0317 : 22Alliance NewsAlliance NewsTOP NEWS: GSK inks licensing deal with CureVac for flu and Covid drugsLSE:GSKGsk Plc
2024/07/0317 : 22Alliance NewsAlliance NewsTOP NEWS: GSK inks licensing deal with CureVac for flu and Covid drugsLSE:GSKGsk Plc
2024/07/0315 : 00RNS Regulatory NewsGSK PLC GSK and CureVac collaboration restructuredLSE:GSKGsk Plc
2024/07/0123 : 00RNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
2024/06/2903 : 43Alliance NewsAlliance NewsIN BRIEF: GSK reaches settlement over Zantac case in IllinoisLSE:GSKGsk Plc
2024/06/2903 : 43Alliance NewsAlliance NewsIN BRIEF: GSK reaches settlement over Zantac case in IllinoisLSE:GSKGsk Plc
2024/06/2901 : 37RNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
2024/06/2416 : 55Alliance NewsAlliance NewsTOP NEWS: GSK hails Omjjara approval in Japan; Jemperli review in EULSE:GSKGsk Plc
2024/06/2416 : 55Alliance NewsAlliance NewsTOP NEWS: GSK hails Omjjara approval in Japan; Jemperli review in EULSE:GSKGsk Plc
2024/06/2415 : 05RNS Regulatory NewsGSK PLC Omjjara approved in Japan for myelofibrosisLSE:GSKGsk Plc
2024/06/2415 : 00RNS Regulatory NewsGSK PLC EMA validates Jemperli marketing authorisationLSE:GSKGsk Plc
2024/06/2123 : 30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
2024/06/1223 : 30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
2024/06/1117 : 32Alliance NewsAlliance NewsTOP NEWS: GSK takes first steps to appeal Zantac ruling in DelawareLSE:GSKGsk Plc
2024/06/1117 : 32Alliance NewsAlliance NewsTOP NEWS: GSK takes first steps to appeal Zantac ruling in DelawareLSE:GSKGsk Plc
2024/06/1115 : 00RNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
2024/06/1103 : 00Alliance NewsAlliance NewsTOP NEWS: GSK welcomes dismissal of Zantac case in IllinoisLSE:GSKGsk Plc
 Showing the most relevant articles for your search:LSE:GSK

最近閲覧した銘柄